Patients with rare diseases will be clear beneficiaries of the European Parliament’s vote on the revised pharmaceutical legislation, says Belgian MEP Frédérique Ries. The pharma package revisions will also embed a European solidarity mechanism, capitalising on European added value.
On 10 April, the European Parliament endorsed a series of far-reaching measures aimed at making medicines more available, accessible, and affordable; while…